Skip to main navigation
Rhythm Pharmaceuticals, Inc. Logo
  • Careers
  • Investors & Media
  • International
  • Search
  • Science
    • MC4R Pathway
    • Clinical Focus
    • Research & Development
  • Clinical Trials
  • Patients
    • Disease Focus
  • Product
  • About
    • Our People
    • Leadership
  • Science
    • MC4R Pathway
    • Clinical Focus
    • Research & Development
  • Clinical Trials
  • Patients
    • Disease Focus
  • Product
  • About
    • Our People
    • Leadership
  • Careers
  • Investors & Media
  • International
  • Search
  • Overview
  • Events & Presentations
  • Stock
  • Corporate Governance
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • News
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact Us

Quarterly Results
Show all

2026

Q1

  • Press Release
  • Webcast
  • Presentation 2.2 MB

2025

Q4

  • Press Release
  • 2025
  • Presentation 2.5 MB

Q3

  • Press Release
  • Webcast
  • Presentation 2.4 MB

Q2

  • Press Release
  • Webcast
  • Form 10-Q

Q1

  • Press Release
  • Webcast
  • Presentation 1.7 MB
  • Form 10-Q

2024

Q4

  • Press Release
  • Webcast
  • Presentation 1.1 MB
  • Form 10-K

Q3

  • Press Release
  • Webcast
  • Presentation 1.8 MB
  • Form 10-Q

Q2

  • Press Release
  • Webcast
  • Presentation 611.3 KB
  • Form 10-Q

Q1

  • Press Release
  • Webcast
  • Presentation 635 KB
  • Form 10-Q
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • California Compliance

Rhythm Pharmaceuticals, Inc.
222 Berkeley Street, 12th Floor
Boston, MA 02116

This website is intended only for residents of the United States.

© 2026, Rhythm Pharmaceuticals, Inc. All Rights Reserved. Rhythm, IMCIVREE, GOLD Academy, LEAD for Rare Obesity, Uncovering Rare Obesity, and their logos are trademarks of Rhythm Pharmaceuticals, Inc.

US-RHY-2400016 05/2024